The judgment by the European Court of Justice in the Damgaard case provides little operational guidance on how to differentiate unlawful advertising for medicinal products from nonpromotional information disseminated by independent journalists, scientists and more generally any third party 1...
Please login to read the full article.Welcome:
IBI01 - Circulation
scr
RAJ Pharma
ECJ Judgment Fails to Clarify Rules on Information and Advertising
26 August 2009
Manuel Campolini
RELATED CONTENT
NEWS
RAJ Pharma News
Other Informa News
ANALYSIS
Other Informa Analysis
EDITORIALS
Other Informa Editorials
FEATURES
RAJ Pharma Features
Other Informa Features
COUNTRY PROFILES
RAJ Pharma Country Profiles
Other Informa Country Profiles
COMMENT
Other Informa Comments
EVENTS
October 4th, 2010
London, UK
October 19th, 2010
Barcelona, Spain
October 20th, 2010
Barcelona, Spain